Did you mean: I. Barmer

Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome

J Lötvall, CA Akdis, LB Bacharier, L Bjermer… - Journal of Allergy and …, 2011 - Elsevier
It is increasingly clear that asthma is a complex disease made up of number of disease
variants with different underlying pathophysiologies. Limited knowledge of the mechanisms of …

Exercise‐induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: Part I of the report from the Joint Task Force of …

KH Carlsen, SD Anderson, L Bjermer, S Bonini… - Allergy, 2008 - Wiley Online Library
Aims: To analyze the changes in the prevalence of asthma, bronchial hyperresponsiveness (BHR)
and allergies in elite athletes over the past years, to review the specific pathogenetic …

MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation

…, M Bewick, T Bieber, C Bindslev‐Jensen, L Bjermer… - Allergy, 2015 - Wiley Online Library
Several unmet needs have been identified in allergic rhinitis: identification of the time of
onset of the pollen season, optimal control of rhinitis and comorbidities, patient stratification, …

MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function

…, GL Stephens, JS Erjefalt, L Bjermer… - Journal of Allergy and …, 2010 - Elsevier
BACKGROUND: Peripheral blood eosinophilia and lung mucosal eosinophil infiltration are
hallmarks of bronchial asthma. IL-5 is a critical cytokine for eosinophil maturation, survival, …

Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)

…, F Maltais, R Abrahams, L Bjermer… - European …, 2015 - Eur Respiratory Soc
Efficacy and safety of tiotropium+olodaterol fixed-dose combination (FDC) compared with
the mono-components was evaluated in patients with moderate to very severe chronic …

Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine

…, M Sue-Chu, A Altraja, L Bjermer… - American journal of …, 2000 - atsjournals.org
Asthma-like symptoms, methacholine hyperresponsiveness, and use of asthma medication
are prevalent in elite cross-country skiers. We quantitated mucosal inflammatory cell …

[HTML][HTML] Reslizumab for inadequately controlled asthma with elevated blood eosinophil levels: a randomized phase 3 study

L Bjermer, C Lemiere, J Maspero, S Weiss, J Zangrilli… - Chest, 2016 - Elsevier
Background This phase 3 study further characterizes the efficacy and safety of reslizumab (a
humanized anti-IL-5 monoclonal antibody) in patients aged 12 to 75 years with asthma …

[HTML][HTML] How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease?

K Herland, JP Akselsen, OH Skjønsberg, L Bjermer - Respiratory medicine, 2005 - Elsevier
Evidence-based medicine is a corner stone in treatment decision making and large
randomised, clinical trials are usually designed in order to provide highly significant results. This …

EUFOREA consensus on biologics for CRSwNP with or without asthma

…, L Bjermer, J Bousquet, GW Canonica, L Deneyer… - Allergy, 2019 - Wiley Online Library
Novel therapies such as type 2 targeting biologics are emerging treatment options for
patients with chronic inflammatory respiratory diseases, fulfilling the needs of severely …

[HTML][HTML] Achieving asthma control in practice: understanding the reasons for poor control

…, ER Shanahan, EV Hillyer, A Tunsäter, L Bjermer - Respiratory …, 2008 - Elsevier
… Leif Bjermer: LB has received grants for lecturing at meetings and conferences from the
following companies: Astra, GSK, Merck, Niigard Pharma, UCB. He and his research unit have …
Did you mean to search for: I. Barmer